Kyoto, Japan

Masaji Nishimura


Average Co-Inventor Count = 3.7

ph-index = 2

Forward Citations = 48(Granted Patents)


Company Filing History:


Years Active: 1989-1996

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Masaji Nishimura: Innovator in Immunology

Introduction

Masaji Nishimura is a prominent inventor based in Kyoto, Japan. He has made significant contributions to the field of immunology, particularly through his innovative patents. With a total of 2 patents, Nishimura's work has advanced the understanding and application of monoclonal antibodies and immunoassays.

Latest Patents

Nishimura's latest patents include a basophil-binding monoclonal antibody and a method for the separation of basophils. The monoclonal antibodies he developed enable the separation of basophils suitable for the IgE-mediated specific chemical mediator release test. This innovation retains reactivity with basophils even after immobilization onto a solid carrier, ensuring that it does not inhibit the release of chemical mediators induced by allergens or anti-IgE antibodies. Additionally, his method simplifies the separation of basophils from blood, making the histamine release test more accessible. The second patent involves a multi-spot enzyme immunoassay method, which allows for the determination of immunologically active substances in biologically derived test samples through a colorimetric measurement process.

Career Highlights

Masaji Nishimura is associated with Shionogi & Company Limited, where he continues to contribute to research and development in immunology. His work has been instrumental in creating more efficient testing methods that benefit both clinical and research settings.

Collaborations

Nishimura has collaborated with notable colleagues, including Junko Uo and Kazuo Horiguchi, to further enhance the impact of his research and innovations.

Conclusion

Masaji Nishimura's contributions to immunology through his patents and collaborative efforts have significantly advanced the field. His innovative approaches to monoclonal antibodies and immunoassays continue to influence research and clinical practices.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…